ABBISKO CAYMAN LIMITED

Insiders Abbisko Cayman Limited

Equities

2256

KYG0028A1085

Delayed Hong Kong S.E. Other stock markets 04:10:01 13/05/2024 BST			5-day change	1st Jan Change
3.47 ^HKD	+0.58%		+0.88%	-5.48%

05-09	Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib	MT
04-29	Abbisko Cayman Limited Appoints Yu Hongping as Joint Company Secretaries	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abbisko Cayman Limited Appoints Yu Hongping as Joint Company Secretaries	04-29	CI
Abbisko Cayman Limited Announces Resignation of Tian Huimin as Joint Company Secretary	04-24	CI
Abbisko Cayman Limited Announces Resignation of Dr. XIA Gavin Guoyao as Non-Executive Director	19/06/23	CI
Abbisko Cayman Appoints New CFO; Shares Jump 3%	17/05/22	MT
Abbisko Cayman Limited Appoints Zhang Zidong as Chief Financial Officer	17/05/22	CI
Abbisko Cayman Limited Announces Resignation of Yeh Richard as Chief Financial Officer, Effective April 28, 2022	26/04/22	CI
Abbisko Cayman Limited Announces Executive, Board and Committee Changes	26/04/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer